GenMark Diagnostics (Nasdaq: GNMK) Coverage Update 2/7/21 Outlook: Bullish PT = $20 (0-24 weeks) About GNMKÂ A commercial-stage medical-diagnostic company marketing its proprietary eSensor … [Read more...] about GNMK Coverage Update
© 2022 · Bio Tech Winners · Privacy Policy
You must be logged in to post a comment.